AMRX

12.54

2.03% -0.26

Dopo l'orario di chiusura: 12.54

Amneal Pharmaceuticals Inc (AMRX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Forum Previsione

Precedente Chiudi:

$12.80

Aprire:

$12.84

Volume 24 ore:

1.47M

Relative Volume:

0.59

Capitalizzazione di mercato:

$4.00B

Reddito:

$3.02B

Utile/perdita netta:

$127.93M

Rapporto P/E:

56.67

EPS:

0.2213

Flusso di cassa netto:

$225.64M

1 W Prestazione:

+0.48%

1M Prestazione:

-6.07%

6M Prestazione:

+25.78%

1 anno Prestazione:

+79.91%

Intervallo 1D:

$12.40

$12.88

Intervallo di 1 settimana:

$12.01

$12.94

Portata 52W:

$6.785

$15.42

Amneal Pharmaceuticals Inc Stock (AMRX) Company Profile

Nome

Amneal Pharmaceuticals Inc

Settore

Healthcare (1106)

Industria

Drug Manufacturers - Specialty & Generic (83)

Telefono

908-947-3120

Indirizzo

400 Crossing Boulevard, 3rd Floor, Bridgewater

Dipendente

5,210

Cinguettio

@amnealpharma

Prossima data di guadagno

2026-02-27

Ultimi documenti SEC

AMRX's Discussions on Twitter

Compare AMRX vs TAK, ZTS, HLN, TEVA, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
AMRX Amneal Pharmaceuticals Inc	12.54	4.08B	3.02B	127.93M	225.64M	0.2213
TAK Takeda Pharmaceutical Co Adr	18.08	58.32B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	117.86	50.46B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	9.84	44.61B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	30.82	36.05B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	571.73	25.19B	3.18B	1.33B	1.04B	27.90

Amneal Pharmaceuticals Inc Stock (AMRX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-12-09	Iniziato	Barclays	Overweight
2025-06-06	Iniziato	Goldman	Buy
2025-02-24	Aggiornamento	JP Morgan	Neutral → Overweight
2024-09-06	Aggiornamento	JP Morgan	Underweight → Neutral
2021-04-07	Ripresa	RBC Capital Mkts	Sector Perform
2021-03-08	Aggiornamento	Goldman	Sell → Buy
2020-12-14	Aggiornamento	Barclays	Equal Weight → Overweight
2020-12-14	Aggiornamento	Guggenheim	Neutral → Buy
2020-07-27	Iniziato	Goldman	Sell
2020-05-12	Aggiornamento	Guggenheim	Sell → Neutral
2019-12-12	Downgrade	Raymond James	Outperform → Mkt Perform
2019-11-12	Downgrade	JP Morgan	Neutral → Underweight
2019-11-07	Downgrade	SVB Leerink	Outperform → Mkt Perform
2019-07-22	Aggiornamento	SVB Leerink	Mkt Perform → Outperform
2019-07-11	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2019-07-08	Aggiornamento	Piper Jaffray	Neutral → Overweight
2019-06-11	Iniziato	Barclays	Equal Weight
2019-05-21	Aggiornamento	Raymond James	Mkt Perform → Strong Buy
2019-03-20	Iniziato	SunTrust	Buy
2019-03-08	Downgrade	SVB Leerink	Outperform → Mkt Perform
2018-12-14	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2018-10-16	Downgrade	SunTrust	Buy → Hold
2018-08-13	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2018-07-23	Iniziato	Morgan Stanley	Overweight
2018-06-22	Iniziato	B. Riley FBR, Inc.	Buy

Mostra tutto

Amneal Pharmaceuticals Inc Borsa (AMRX) Ultime notizie

02:31 AM

Fund Flows: Is Amneal Pharmaceuticals Inc forming a double bottomEarnings Overview Summary & Fast Momentum Entry Tips - baoquankhu1.vn

02:31 AM

Apr 10, 2026

Here's the way AMRX is leveraging the demand for GLP-1 via its manufacturing operations - Bitget

Apr 10, 2026

Why Amneal Pharmaceuticals (AMRX) Stands Out as a Leading Long-Term Growth Stock - Bitget

Apr 10, 2026

Why Amneal Pharmaceuticals (AMRX) is a top growth stock for the long term - MSN

Apr 10, 2026

Apr 09, 2026

A Look At Amneal Pharmaceuticals (AMRX) Valuation After Launching Its New Glaucoma Generic - Yahoo Finance

Apr 09, 2026

FDA sends latest Untitled Letters to Amneal, BioCorRx over brochures, websites - Medical Marketing and Media

Apr 09, 2026

Amneal Launches Bimatoprost Ophthalmic Solution, 0.01% - Bitget

Apr 09, 2026

Amneal rolls out generic glaucoma eye drop in a $719M U.S. market - Stock Titan

Apr 09, 2026

Apr 08, 2026

AMRX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Apr 08, 2026

Volatility Watch: Whats the fair value of Amneal Pharmaceuticals Inc stock2026 Historical Comparison & Proven Capital Preservation Tips - baoquankhu1.vn

Apr 08, 2026

Amneal marks Parkinson's Awareness Month, $2M donation - Post Register

Apr 08, 2026

Apr 07, 2026

Amneal to Report First Quarter 2026 Results on May 1, 2026 - The Manila Times

Apr 07, 2026

$2M from Amneal targets Parkinson's drug costs for patients - Stock Titan

Apr 07, 2026

Apr 06, 2026

Trading Recap: Whats the fair value of Amneal Pharmaceuticals Inc stockRate Cut & Low Volatility Stock Recommendations - baoquankhu1.vn

Apr 06, 2026

Apr 05, 2026

Allspring Global Investments Holdings LLC Grows Stock Position in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat

Apr 05, 2026

Apr 04, 2026

Pharma News: Is Amneal Pharmaceuticals Inc in a long term uptrend2026 Geopolitical Influence & Technical Pattern Recognition Alerts - baoquankhu1.vn

Apr 04, 2026

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives Average Rating of "Buy" from Brokerages - MarketBeat

Apr 04, 2026

Apr 02, 2026

Amneal Pharmaceuticals Stock: Generic Drug Leader Faces Recall Challenges Amid Sector Growth Opportu - AD HOC NEWS

Apr 02, 2026

Mar 31, 2026

Tudor Investment Corp ET AL Takes Position in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat

Mar 31, 2026

JPMorgan Chase & Co. Has $7.72 Million Stock Position in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat

Mar 31, 2026

Mar 30, 2026